NBTX Nanobiotix S.A. - ADSs

NASDAQ · Biotechnology
$43.18
Price · Aug 19, 2026

NBTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$43.18
Market Cap
P/E (TTM)
EPS (TTM)
Revenue (TTM)
Div Yield
ROE
Debt/Equity
52W Range
$8 – $57

NBTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
NBTX
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
NBTX
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
NBTX
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
NBTX
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
NBTX
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
NBTX
Peer Median

NBTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 12 analysts
  • Strong Buy 4 33.3%
  • Buy 6 50.0%
  • Hold 2 16.7%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

3 analysts · 2026-08-15
Median target $35.88 -16.9%
Mean target $45.13 +4.5%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-0.36%
Period EPS Actual EPS Est Surprise
Dec. 31, 2025 $-0.39 $0.56 -0.95%
June 30, 2025 $-0.11 $-0.32 0.21%
Dec. 31, 2024 $-0.98 $-0.55 -0.43%
June 30, 2024 $-0.46 $-0.21 -0.25%
Dec. 31, 2023 $-0.28 $0.10 -0.38%

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 19 filers · $217.0M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
7 (+5 vs prior Q) 3 (+2 vs prior Q) 5 (+2 vs prior Q) 3 (-2 vs prior Q) +94K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
JOHNSON & JOHNSON $212,017,863 5,623,816 97.72% Shares
MORGAN STANLEY $1,877,045 49,789 0.87% Shares
JANE STREET GROUP, LLC $1,213,186 32,180 0.56% Shares
XTX Topco Ltd $597,734 15,855 0.28% Shares
Optiver Holding B.V. $513,889 13,631 0.24% Shares
CITADEL ADVISORS LLC $227,783 6,042 0.10% Shares
BNP PARIBAS FINANCIAL MARKETS $152,459 4,044 0.07% Shares
UBS Group AG $97,153 2,577 0.04% Shares
ROYAL BANK OF CANADA $83,000 2,189 0.04% Shares
JPMORGAN CHASE & CO $61,348 1,706 0.03% Shares
RHUMBLINE ADVISERS $56,622 1,502 0.03% Shares
GAMMA Investing LLC $37,135 985 0.02% Shares
OSAIC HOLDINGS, INC. $18,850 500 0.01% Shares
WELLS FARGO & COMPANY/MN $7,540 200 0.00% Shares
Stone House Investment Management, LLC $2,865 76 0.00% Shares
MARSHALL WACE, LLP $2,149 57 0.00% Shares
Federation des caisses Desjardins du Quebec $2,111 56 0.00% Shares
HRT FINANCIAL LP $1,030 27,332 0.00% Shares
NATIONAL BANK OF CANADA /FI/ $482 13 0.00% Shares

ETF ownership Held by 1 ETF

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
APIE · Trust for Professional Managers 0.01% 1,295 NS May 31, 2026 N-PORT